Yutaka Enomoto

Minato, 1088639, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance.

Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance.

Journal: Molecular cancer therapeutics
Published: August 18, 2025

IgE-dependent anaphylaxis is regulated by sphingolipid binding to activating and inhibitory CD300 family members.

IgE-dependent anaphylaxis is regulated by sphingolipid binding to activating and inhibitory CD300 family members.

Journal: Cell reports
Published: June 16, 2025

Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.

Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis.

Journal: International journal of urology : official journal of the Japanese Urological Association
Published: September 21, 2024

Prostaglandin E2-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells.

Prostaglandin E2-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells.

Journal: Nature communications
Published: May 30, 2024

Clinical manifestations of interstitial cystitis and bladder pain syndrome: Analysis of a patient registry in Japan.

Clinical manifestations of interstitial cystitis and bladder pain syndrome: Analysis of a patient registry in Japan.

Journal: International journal of urology : official journal of the Japanese Urological Association
Published: April 11, 2024

SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation.

SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation.

Journal: Cell reports
Published: November 17, 2023

Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomy.

Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomy.

Journal: Scientific reports
Published: October 08, 2023

Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched study.

Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched study.

Journal: International journal of urology : official journal of the Japanese Urological Association
Published: June 02, 2023

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.

Validation of a drug-based score in advanced urothelial carcinoma treated with pembrolizumab.

Journal: Immunotherapy
Published: May 16, 2023

Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment.

Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment.

Journal: Cell reports
Published: December 20, 2022

Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.

Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.

Journal: Communications biology
Published: September 20, 2022

Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.

Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective study.

Journal: World journal of urology
Published: September 12, 2022
Showing 1-12 of 65

Last Updated: 09/26/2026